An analysis of Awanui Labs' financial losses and monopoly position reveals growing concerns about the sustainability of New Zealand's pathology services and the risks of overreliance on a single provider in the public health system.
Stacked weekly counts; colour by lean. “n/a” covers government and iwi-Māori sources where lean isn't applicable.
How this topic has been named, week by week. A new alias winning out is usually a framing shift.
How the news corpus has covered this same topic over the last 12 weeks. 3 articles from RNZ, Stuff, NZ Herald, ODT, 1News, Newsroom and The Spinoff. Click through to the press view for the full panel.
Up to 12 framings spread across orientations. Each framing is a short phrase the topic extractor generated to characterise the piece's stance — not a quote from the source. Click through to read the original.
under pressure from systemic cost pressures
An uncomfortable truth: NZ’s money-losing medical monopoly is too big to failSpotted something wrong on this page? Report a correction.